After being a resident living in the UK and EU, learning the legal foundations and delicate intricacies of British and European Commercial Law and Intellectual Property rights, it still amazes me how these two powerful entities could still place the weakest and most needy in society at peril over the political aspirations of a […]
An article by Robert Guth in the Wall Street Journal last week highlighted the theory that I posed in last Thursday’s post, that our global health system is designed to be reactionary and emergency-focused: That question goes to the heart of one of the most controversial debates in global health: Is humanity better served by […]
I feel a little bad for the big pharmaceutical companies. Their big announcement today amounted to little more than a mention in the “more news” section of the NYTimes, sidelined by breathless articles about Obama signing the health reform bill. But more news is truly big news: both Pfizer and GlaxoSmithKline have signed up to give […]